Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy

We analyzed a cohort of 26 patients with chronic myeloid leukemia who had failed imatinib and a second tyrosine kinase inhibitor but were still in first chronic phase and identified prognostic factors for response and outcomes. The achievement of a prior cytogenetic response on imatinib or on second...

Full description

Saved in:
Bibliographic Details
Published in:Blood
Main Authors: Ibrahim, Amr R., Paliompeis, Christos, Bua, Marco, Milojkovic, Dragana, Szydlo, Richard, Khorashad, Jamshid S., Foroni, Letizia, Reid, Alistair, de Lavallade, Hugues, Rezvani, Katayoun, Dazzi, Francesco, Apperley, Jane F., Goldman, John M., Marin, David
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2010
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6143154/
https://ncbi.nlm.nih.gov/pubmed/20833982
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-06-291922
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items